1. Home
  2. BLIN vs SNGX Comparison

BLIN vs SNGX Comparison

Compare BLIN & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

HOLD

Current Price

$1.01

Market Cap

12.9M

Sector

Technology

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.40

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLIN
SNGX
Founded
2000
1987
Country
United States
United States
Employees
40
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
11.2M
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
BLIN
SNGX
Price
$1.01
$0.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.62
$6.00
AVG Volume (30 Days)
55.1K
10.2M
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.03
EPS
N/A
N/A
Revenue
$13,568,000.00
$119,371.00
Revenue This Year
$22.67
N/A
Revenue Next Year
$21.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$0.28
52 Week High
$1.74
$6.23

Technical Indicators

Market Signals
Indicator
BLIN
SNGX
Relative Strength Index (RSI) 46.70 39.82
Support Level $0.77 $0.28
Resistance Level $1.09 $0.41
Average True Range (ATR) 0.10 0.05
MACD -0.02 -0.01
Stochastic Oscillator 12.15 0.56

Price Performance

Historical Comparison
BLIN
SNGX

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: